Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks.
Pubmed ID: 29541747
Pubmed Central ID: PMC5875301
Journal: JAMA cardiology
Publication Date: April 1, 2018
MeSH Terms: Humans, Cardiovascular Diseases, Randomized Controlled Trials as Topic, Data Interpretation, Statistical, Adrenergic beta-Antagonists, Treatment Outcome, Propanolamines, Mortality, Time Factors, Statistics as Topic
Grants: R21 AG049385, R01 HL136942
Authors: Zhao L, Tian L, Wei LJ, Claggett B, Solomon S, Kim DH, Pfeffer M
Cite As: Zhao L, Tian L, Claggett B, Pfeffer M, Kim DH, Solomon S, Wei LJ. Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks. JAMA Cardiol 2018 Apr 1;3(4):357-358.
Studies:
Abstract
This study explores using the restricted mean time lost to quantify treatment effects from cardiovascular therapy.